Cefoxitin sodium salt Cas: 33564-30-6
| Catalog Number | XD92174 |
| Product Name | Cefoxitin sodium salt |
| CAS | 33564-30-6 |
| Molecular Formula | C16H16N3NaO7S2 |
| Molecular Weight | 449.44 |
| Storage Details | 2 to 8 °C |
| Harmonized Tariff Code | 29419000 |
Product Specification
| Appearance | White to off-white powder |
| Assay | 99% min |
| Water | <1.0% |
| Specific rotation | +206 ° C~+214 ° C |
| Conclusion | This product complies with USP Standard |
| Heavy metals | <0.002% |
| pH | 4.2~7.0 |
| Bacterial endotoxin | <0.2EU/mg |
| Solubility | Very soluble in water. Soluble in methanol. Sparingly soluble in DMF and acetone. Insoluble in ether and chloroform |
| Sterility | Meets the requirement |
| Crystallinity | Meets the requirement |
| Identifcation | A: The chromatogram of the assay preparation obtained as directed in the assay exhibits a major peak for cefoxitin, the retention time of which corresponds to that exhibited in the chromatogram of the standard preparation obtained as directed in the Assay. B: UV. C: It responds to tests for sodium. |
| Limit of Acetone | <0.7% |
| Limit of Methanol | <0.1% |
The product is a semi synthetic second generation cephalosporin, characterized by strong antibacterial effect on Gram-negative bacteria and highly resistant to beta lactamase. The antimicrobial spectrum includes Escherichia coli, pneumoniae, indole positive Proteus, Serratia, Klebsiella, influenza, Salmonella, Shigella, etc. It also has a good effect on Staphylococcus and a variety of Streptococcus.
It is mainly used for respiratory tract infections, endocarditis, peritonitis, pyelonephritis, urinary tract infection, septicemia and bone, joint, skin and soft tissue infections caused by susceptible bacteria.
Close
